HCA Healthcare Inc. (HCA)
NYSE: HCA
· Real-Time Price · USD
362.75
9.05 (2.56%)
At close: May 12, 2025, 3:59 PM
362.99
0.07%
After-hours: May 12, 2025, 06:41 PM EDT
HCA Healthcare Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Revenue | 1.68B | 1.51B | 1.32B | 1.34B | 1.12B | 1.16B | 1.16B | 1.1B | 1.2B | 1.29B | 1.31B | 1.18B | 1.06B | 938M |
| International Revenue Growth | +11.46% | +14.58% | -1.42% | +19.29% | -3.61% | +0.52% | +5.38% | -8.20% | -7.72% | -1.22% | +11.57% | +10.85% | +13.01% | n/a |
| Managed Care And Other Insurers Revenue | 34.95B | 31.82B | 29.12B | 30.3B | 26.54B | 26.54B | 24.47B | 24.81B | 23.44B | 21.88B | 20.07B | 18.65B | 18B | 15.7B |
| Managed Care And Other Insurers Revenue Growth | +9.85% | +9.27% | -3.88% | +14.17% | -0.03% | +8.49% | -1.39% | +5.85% | +7.12% | +9.05% | +7.57% | +3.64% | +14.62% | n/a |
| Managed Medicaid Revenue | 3.98B | 3.88B | 4B | 3.12B | 2.62B | 2.45B | 2.4B | 2.35B | 2.48B | 2.23B | 1.92B | 1.57B | 1.5B | 1.26B |
| Managed Medicaid Revenue Growth | +2.60% | -2.98% | +27.98% | +19.19% | +6.98% | +1.96% | +2.30% | -5.21% | +10.92% | +16.17% | +22.48% | +4.39% | +18.89% | n/a |
| Managed Medicare Revenue | 11.99B | 10.5B | 9.2B | 8.42B | 7B | 6.45B | 5.5B | 4.79B | 4.36B | 4.13B | 3.61B | 3.28B | 2.95B | 2.44B |
| Managed Medicare Revenue Growth | +14.21% | +14.07% | +9.22% | +20.39% | +8.45% | +17.37% | +14.81% | +9.94% | +5.37% | +14.36% | +10.22% | +11.00% | +20.97% | n/a |
| Medicaid Revenue | 4.68B | 3.61B | 2.64B | 2.29B | 1.97B | 1.57B | 1.36B | 1.63B | 1.6B | 1.71B | 1.85B | 1.48B | 1.46B | 1.84B |
| Medicaid Revenue Growth | +29.73% | +36.80% | +15.11% | +16.54% | +25.00% | +15.76% | -16.74% | +2.13% | -6.33% | -7.74% | +24.86% | +1.09% | -20.65% | n/a |
| Medicare Revenue | 10.78B | 10.59B | 10.45B | 10.45B | 10.42B | 10.8B | 9.83B | 9.48B | 8.89B | 8.65B | 8.35B | 7.95B | 8.29B | 7.65B |
| Medicare Revenue Growth | +1.84% | +1.32% | 0.00% | +0.26% | -3.50% | +9.84% | +3.67% | +6.61% | +2.78% | +3.59% | +5.07% | -4.11% | +8.35% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8B | 7.92B | 7.86B | 7.68B | 7.71B | 7.57B | 7.56B | 7.28B | 7.08B | 7.05B | 6.9B | 6.79B | 6.94B | 7B | 7.09B | 6.38B | 6.3B | 6.33B | 6.1B | 5.33B | 6.12B | 6.11B | 5.97B | 5.84B | 5.65B | 5.49B | 5.38B | 5.27B | 5.29B | 5.18B | 5.08B | 4.9B | 4.9B | 4.76B | 4.74B | 4.69B | 4.7B | 4.61B | 4.62B | 4.49B | 4.4B |
| Selling, General, and Administrative Revenue Growth | +1.01% | +0.71% | +2.29% | -0.29% | +1.81% | +0.19% | +3.83% | +2.72% | +0.41% | +2.26% | +1.58% | -2.12% | -0.86% | -1.34% | +11.10% | +1.33% | -0.44% | +3.81% | +14.39% | -12.88% | +0.21% | +2.24% | +2.30% | +3.36% | +2.95% | +2.01% | +1.95% | -0.28% | +2.08% | +1.97% | +3.78% | -0.10% | +2.88% | +0.51% | +1.04% | -0.23% | +2.08% | -0.28% | +2.83% | +2.14% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |